Background Image
Table of Contents Table of Contents
Previous Page  89 96 Next Page
Information
Show Menu
Previous Page 89 96 Next Page
Page Background

[15]

Lyratzopoulos G, Abel GA, McPhail S, Neal RD, Rubin GP. Gender inequalitiesin the promptness ofdiagnosisof bladderand renal cancer after symptomatic presentation: evidence from secondary analysis of an English primary care audit survey. BMJ Open 2013; 3:e002861

.

[16]

Horstmann M, Witthuhn R, Falk M, Stenzl A. Gender-specific differ- ences in bladder cancer: a retrospective analysis. Gend Med 2008; 5: 385–94

.

[17]

Mungan NA, Aben KK, Schoenberg MP, et al. Gender differences in stage-adjusted bladder cancer survival. Urology 2000;55:876–80.

[18]

Gakis G, Stenzl A. Gender-specific differences in muscle-invasive bladder cancer: the concept of sex steroid sensitivity. World J Urol 2013;31:1059–64.

[19]

Wallace DM. Occupational urothelial cancer. Br J Urol 1988;61: 175–82.

[20]

Dickman PW, Coviello E, Hills M.

Estimating and modelling

relative

survival using

Stata; 2012

http://pauldickman.com/rsmodel/stata_ colon/

[21]

Scrucca L, Santucci A, Aversa F. Competing risk analysis using R: an easy guide for clinicians. Bone Marrow Transplant 2007;40:381–7

.

[22]

Gray R. A class of k-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988;16:1141–54.

[23]

Fajkovic H, Halpern JA, Cha EK, et al. Impact of gender on bladder cancer incidence, staging, and prognosis. World J Urol 2011;29: 457–63.

[24]

Noon AP, Albertsen PC, Thomas F, Rosario DJ, Catto JW. Competing mortality in patients diagnosed with bladder cancer: evidence of undertreatment in the elderly and female patients. Br J Cancer 2013;108:1534–40.

[25]

Henning A, Wehrberger M, Madersbacher S, et al. Do differences in clinical symptoms and referral patterns contribute to the gender gap in bladder cancer? BJU Int 2013;112:68–73.

[26]

Johnson EK, Daignault S, Zhang Y, Lee CT. Patterns of hematuria referral to urologists: does a gender disparity exist? Urology 2008; 72:498–502.

[27]

Konety BR, Joslyn SA. Factors influencing aggressive therapy for bladder cancer: an analysis of data from the SEER program. J Urol 2003;170:1765–71.

[28]

Nielsen ME, Palapattu GS, Karakiewicz PI, et al. A delay in radical cystectomy of > 3 months is not associated with a worse clinical outcome. BJU Int 2007;100:1015–20.

[29]

Munro NP, Sundaram SK, Weston PM, et al. A 10-year retrospective review of a nonrandomized cohort of 458 patients undergoing radical radiotherapy or cystectomy in Yorkshire, UK. Int J Radiat Oncol Biol Phys 2010;77:119–24.

[30]

Gore JL, Lai J, Setodji CM, Litwin MS, Saigal CS. Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a Surveillance, Epidemiology, and End Results-Medicare analysis. Cancer 2009;115:988–96.

E U R O P E A N

U R O L O G Y

F O C U S

1

( 2 0 1 5

)

8 2 – 8 9

89